Stay updated on Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial

Sign up to get notified when there's something new on the Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Added site revision note 'Revision: v3.4.2'. Removed the operating-status notice about lapse in government funding and the earlier 'Revision: v3.4.1' note.
    Difference
    0.4%
    Check dated 2026-02-11T14:21:39.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a government funding lapse notice at the top of the page and updated the site to version v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:39:53.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Glossary visibility was added, the 'Last Update Submitted' label was standardized to 'Last Update Submitted that Met QC Criteria', a 'No FEAR Act Data' notice was included, and the revision was updated to v3.4.0 (replacing v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T06:37:59.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page shows an update to the revision metadata with an addition of 'Revision: v3.3.4' and a deletion of 'Revision: v3.3.3'. This appears to be a metadata/versioning update and does not modify study content, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:46:05.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    A new 'Locations' section has been added, including New Jersey and New York. The previous 'New Jersey Locations' and 'New York Locations' sections have been removed.
    Difference
    0.3%
    Check dated 2025-12-23T17:16:40.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Added note that publications are automatically filled from PubMed and may not be about the study, and updated the page revision to v3.3.2. The previous PubMed publication description and the old revision text were removed (v3.2.0).
    Difference
    0.1%
    Check dated 2025-11-24T21:33:01.000Z thumbnail image

Stay in the know with updates to Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial page.